Stakeholders in Nigeria’s pharmaceutical industry have expressed concern that the recently introduced two-year import duty and VAT waiver on pharmaceutical raw materials may fall short of expectations unless the Federal …
AFRICA NEWSBusiness PoliciesEconomyHealthcareInfrastructureNigeriaPolicies